From Teleoperation to Autonomy: What the Patent Record Shows

Autonomous robotic surgery encompasses computer-controlled, image-guided, and semi-autonomous systems capable of executing or assisting surgical tasks with reduced or no direct real-time human manipulation — and the patent record from 2011 to 2026 documents a decisive shift away from purely teleoperated paradigms. Across 70+ patent and literature records surveyed for this landscape, a consistent architectural motif emerges: the master–slave or cooperative-control architecture, in which degrees of operator authority are progressively replaced by computational autonomy.

The dataset resolves into four mechanistically distinct but frequently overlapping technical domains: autonomous or semi-autonomous motion control and navigation of robotic manipulators; image-guided and sensor-fused trajectory planning; tendon-driven and articulated instrument actuation; and collision avoidance and safety monitoring. These domains span applications from vascular interventional robots navigating blood-vessel lumens using intraoperative imaging to multi-robot controllers that autonomously revise surgical plans when one arm cannot reach its target.

The publication timeline reveals four distinct maturity phases. The foundational period (2011–2017) established core kinematic structures — 6-DOF manipulators, remote-centre-of-motion joints, and the macro/micro-positioner cascade architecture filed by Medical Microinstruments S.R.L. in Italy in 2017, which reappears across at least seven subsequent records. The rapid scale-up phase (2018–2021) shows the highest density of foundational filings, including Koninklijke Philips N.V.’s first image-guided convergent ablation patent family (EP, 2018) and early AI integration signals from Samsung Electronics’ machine-learning movement prediction filing (KR, 2014). Commercialisation and AI integration (2022–2024) introduced work-volume mapping for dynamic collision avoidance, augmented reality navigation, and biomechanical-model-driven instrument guidance. The most recent records (2025–2026) signal a pivot toward fully integrated, multi-modal autonomous execution.

Four Technical Clusters Driving Autonomous Surgical Robotics

The patent landscape organises into four mechanistically distinct clusters, each addressing a different layer of the autonomy stack — from perception and planning through to safe physical execution. Understanding these clusters is essential for IP strategists mapping freedom-to-operate or for R&D teams identifying white-space opportunities.

Cluster 1: Autonomous Navigation via Intraoperative Imaging

The most heavily represented technical cluster links intraoperative image acquisition — endoscopic, fluoroscopic, CT, or ultrasound — to autonomous or semi-autonomous motion commands, eliminating constant manual guidance. Controllers analyse image data in real time to generate navigation paths, compensate for patient motion such as respiration, and update surgical plans when obstructions are detected. Beijing WeMed Medical Equipment Co., Ltd.’s 2023 filing describes a processor-driven intraoperative image analysis system that generates automatic navigation commands for intravascular catheter advancement, with manual override capability. Koninklijke Philips N.V.’s 2025 EP filing goes further: its controller autonomously navigates multiple surgical robots relative to cardiac anatomy and revises the surgical plan in real time when a robot cannot follow the original trajectory — a clear example of supervised autonomy in a clinical setting.

Cluster 2: Tendon-Driven Articulated Instrument Control

A significant sub-domain, heavily populated by Medical Microinstruments Inc./S.p.A., covers the precision control of tendon-actuated end effectors — essential for microsurgery and tight anatomical spaces. Patents address elastoplastic tendon elongation compensation, calibration, motion scaling, and degree-of-freedom limiting to avoid operating-limit violations. The 2025 KR filing estimates desired target force during actuator contact with drive tendons, compensating for tendon deformation during live surgery. A 2023 KR filing introduces a partial-autonomy mode in which only a subset of degrees of freedom follow the master device, enabling semi-autonomous assistance — a nuanced control architecture that sits between full teleoperation and full autonomy.

Cluster 3: Collision Avoidance and Workspace Safety

A dedicated cluster addresses the challenge of preventing unintended robot-arm collisions with patients, staff, and other arms — an essential safety prerequisite for autonomous operation, as noted in safety standards from ISO. Approaches range from proximity-sensor-based prediction to torque-residual analysis. CMR Surgical Ltd.’s 2023 JP filing enables inter-arm collision detection through residual torque analysis at each joint, without requiring knowledge of relative arm positions. Mazor Robotics Ltd.’s 2024 CN filing explicitly describes a machine-learning model that predicts object motion during surgery and preemptively updates the robot’s navigation path — a departure from reactive, sensor-only collision responses.

Cluster 4: Preoperative Planning with AR/XR Integration

An increasingly prominent cluster integrates preoperative CT/imaging, 3D anatomical models, and augmented or extended reality overlays to enable precise intraoperative guidance and semi-autonomous tool positioning. Globus Medical Inc.’s 2022 JP filing uses stereophotogrammetric infrared cameras to detect active and passive tracking markers, determining 3D positions of instruments and patients to enable automated trajectory execution. Quantum Surgical’s 2025 JP filing generates predictive models of marker motion across respiratory cycles and overlays 3D anatomical models in augmented reality to guide intervention timing — a critical enabler for autonomous hepatic, renal, or pulmonary procedures.

“A machine-learning model predicts object motion during surgery and preemptively updates the robot’s navigation path — a departure from reactive, sensor-only collision responses.”

Who Holds the IP: Assignee and Jurisdiction Landscape

Three assignees — Koninklijke Philips N.V., Medical Microinstruments Inc./S.p.A., and Globus Medical Inc. — account for roughly one-third of all records in the dataset, making this a moderately concentrated landscape. However, a long tail of specialised companies including Quantum Surgical, Zeta Surgical, SSI IP Holdings, Relievant Medsystems, and Virtual Incision signals that the competitive perimeter is widening rapidly.

Japan (JP) is the dominant filing jurisdiction, with at least 40 of the retrievable patent records carrying JP jurisdiction. This strongly reflects PCT and US-origin families entering Japan, not necessarily Japanese-origin innovations. Korea (KR) accounts for approximately 10 records, mostly from Medical Microinstruments and a Beijing-based surgical technology company. Italy (IT) holds approximately 5 records, almost exclusively from Medical Microinstruments S.p.A./S.r.l., indicating this Italian company protects core IP domestically. Europe (EP) holds 2 records, both Philips convergent ablation filings from 2018 and 2025, suggesting broad European protection for a key autonomous navigation family.

Application Domains: Where Autonomous Surgery Is Being Deployed

Autonomous robotic surgery patents in this dataset span five distinct clinical application domains, each with its own leading assignees, technical requirements, and regulatory considerations. According to WHO global health priorities, minimally invasive surgical access and precision in high-stakes procedures such as cardiac ablation and spinal surgery represent areas of significant unmet clinical need — precisely where the most active patent clusters are concentrated.

Minimally invasive soft tissue and laparoscopic surgery is the largest application cluster. Records from Ethicon LLC, Covidien Limited Partnership, the Board of Regents of the University of Nebraska, and Virtual Incision Corporation cover instrument drive configurations, sterile interface modules, multi-DOF manipulators, and in-body robotic devices for laparoscopic and endoscopic procedures. The University of Nebraska’s 2021 JP filing describes an in-vivo robotic device with a camera lumen placed through a body-cavity orifice — a compact form factor that points toward next-generation single-port autonomous systems.

Orthopaedic and spinal surgery forms a distinct cluster focused on bone preparation, implant placement, and neuromonitoring-integrated robotic systems. KB Medical S.A.’s 2021 JP filing describes robot-guided osteotomy with neuromonitoring integration that prevents bone over-resection. MAKO Surgical Corporation’s 2021 KR filing introduces autonomous and manual modes for screw placement, with rotation speed proportional to known thread geometry — a fine example of task-specific conditional autonomy that aligns with frameworks discussed by FDA for autonomous device classification.

Cardiac and interventional procedures are represented most clearly by Philips’ convergent ablation family, which constitutes the clearest example in the dataset of full autonomous multi-robot surgical execution applied to cardiac ablation. The 2024 JP filing describes a dependent robotic arm that moves automatically as a geometric function of the independent arm’s operator-controlled motion — a cooperative autonomy model that reduces cognitive load on the operating surgeon.

Microsurgery is dominated by Medical Microinstruments S.p.A./Inc., whose cascade macro/micro-positioner architecture and tendon-driven instrument families are expressly designed for sub-millimetre precision. The 2023 JP filing describes master-tool tracking with tendon-contact-surface geometry optimised for microsurgical joint sub-assemblies.

Telesurgery and remote collaboration represent the newest and fastest-growing application domain. SSI IP Holdings Inc.’s 2026 JP filings describe private-network-coupled multi-arm systems enabling remote surgeons to control local robotic arms — a configuration that converges with Beijing WeMed’s vascular navigation platform to point toward a future where surgical robots execute plans transmitted from geographically remote experts. Research published by Nature has highlighted latency compensation as a critical technical barrier for telesurgical systems, an area not yet densely covered in this patent dataset.

Five Emerging Directions Shaping 2026 and Beyond

Based on filings dated 2023–2026 in this dataset, five forward-looking directions are identifiable — each representing a distinct technical bet on how autonomous surgical robotics will evolve from supervised assistance toward conditional and conditional-full autonomy.

1. Predictive Collision Avoidance via Machine Learning. The Mazor Robotics CN filing (2024) explicitly describes a machine-learning model that predicts object motion during surgery and preemptively updates the robot’s navigation path — a departure from reactive, sensor-only collision responses that characterised earlier filings in this dataset.

2. Biomechanical-Model-Driven Autonomous Targeting. Quantum Surgical’s 2025 JP filing uses a stored biomechanical model of the human body combined with real-time image capture to compute position and orientation setpoints autonomously, compensating for organ motion without explicit user input at each step.

3. Respiratory-Cycle-Synchronized Intervention. Quantum Surgical’s augmented reality navigation system (JP, 2025) generates predictive models of respiratory marker motion to identify the optimal moment for robotic intervention — a critical enabler for autonomous hepatic, renal, or pulmonary procedures where organ displacement during breathing is a primary source of targeting error.

4. Dual-End-Effector Collaborative Robots. B. Braun New Ventures GmbH’s records (DE, 2024; JP, 2026) describe a single robot arm carrying both a visualization unit and a surgical instrument, with the control unit autonomously managing their spatial relationship — compressing system footprint while maintaining dual functionality.

5. Networked Multi-Arm Telesurgical Platforms. SSI IP Holdings Inc.’s 2026 JP filings describe preoperative planning systems and multi-arm remote surgery platforms that link local and remote surgeon consoles over private networks, pointing toward autonomous execution of pre-planned tasks at remote sites. This vector will require IP coverage spanning communication protocols, latency compensation, and remote authority hand-off — areas not yet densely covered in this dataset.

Strategic Implications for IP and R&D Teams

The patent landscape described here carries direct implications for IP strategy, R&D prioritisation, and competitive positioning — particularly as regulatory bodies such as FDA and EMA begin to develop classification frameworks for autonomous surgical devices.

Autonomy is the next regulatory frontier. The dataset shows a clear shift from passive navigation assistance toward autonomous plan revision and motion execution, as evidenced by filings from Philips, Quantum Surgical, and Mazor. IP strategists should map their portfolios against the autonomy spectrum — assistance, guidance, supervised autonomy, conditional autonomy — as regulatory classification will follow the same axis. The PatSnap IP Intelligence platform provides portfolio mapping tools suited to this kind of regulatory-aligned analysis.

Tendon-drive precision is an underserved but protectable moat. Medical Microinstruments’ dense cluster of KR and IT filings around tendon elongation compensation, calibration, and degree-of-freedom limiting covers a narrow but critical mechanical sub-problem. Competitors entering microsurgery must navigate or design around this IP before reaching the market.

Tracking infrastructure is becoming a platform layer. Globus Medical’s large tracking-marker automation family (7+ JP filings) and Zeta Surgical’s image-based cooperative control suggest that intraoperative tracking is transitioning from a peripheral accessory to a core autonomous control substrate. R&D teams should consider tracking modality — optical, electromagnetic, or image-based — as an architectural decision with a long IP tail.

Telesurgery and remote autonomy represent the highest-growth vector. SSI IP Holdings’ 2026 multi-arm remote surgery system and Beijing WeMed’s vascular navigation platform converge on a future where surgical robots execute plans transmitted from geographically remote experts. This vector will require IP coverage spanning communication protocols, latency compensation, and remote authority hand-off. Teams using PatSnap’s R&D intelligence tools can monitor emerging filings in this space as they publish.

“Intraoperative tracking is transitioning from a peripheral accessory to a core autonomous control substrate — R&D teams should treat tracking modality as an architectural decision with a long IP tail.”

Chinese OEM activity warrants dedicated monitoring. Only MicroPort (Shanghai) MedBot and Mazor’s CN filing appear in this dataset as China-linked records. Given China’s established surgical robotics manufacturing base — including Tinavi, MicroPort, and Microbot — the absence of more CN-origin filings in this dataset likely reflects search-scope limitations. IP strategists should conduct dedicated CN-jurisdiction searches to complete the competitive picture.